Investor Presentaiton
1
Key RMS Growth Drivers
Current Target:
6%-8%
2023-2026E RMS organic revenue CAGR
Drive Insourcing Solutions
and CRADL™ growth
Expand CRADLTM in additional
geographies to ensure regional
biohub coverage
4
2
Target growth in biohubs
Targeted sales strategies aimed at
growing biotech and academic
markets
Enhance digital enterprise
Enhance e-commerce, data
personalization, and further
digitalization of the client experience
5
3
ulk
Continue China expansion
Strong growth with ramping up capacity
utilization of the research model
production footprint and diversifying the
range of services, including CRADL™
Growing focus on
cell therapy
Continue to enhance offering around
cell therapy and other advanced
therapies
Charles River Laboratories (CRL)
4View entire presentation